Company profile: CellRight Technologies
1.1 - Company Overview
Company description
- Provider of regenerative medicine solutions, developing osteoinductive and wound care scaffolds to improve healing of trauma- and disease-related defects. Offerings include dCELL soft tissue decellularization, BioRinse osteoinductive bone fillers, DermaPure dermal allografts, ConCelltrate bone grafts, AmnioWorks birth tissue barriers, and SurgiPure XD porcine xenografts. Serves Texas.
Products and services
- DCELL® Technology: A clinical-grade soft tissue decellularization process that removes DNA and cellular material, creating biological scaffolds to reduce rejection and enable tissue regeneration for improved healing
- BioRinse™ Technology: A medical-grade osteoinductive bone filler made from 100% allograft bone, stimulating and regenerating native bone growth
- DermaPure®: A surgical-grade decellularized dermal allograft for managing soft tissue defects, delivering structural support and promoting tissue regeneration
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CellRight Technologies
Relign
HQ: United States
Website
- Description: Provider of arthroscopes and an arthroscopy system that combines fluid management, ablation, tissue resection, and bone cutting in a single shaver handpiece with a reusable, sterilizable handle and single umbilical cable. Offers suture anchors (JuggerKnot, SureLock, Quattro X, ComposiTCP) for soft tissue fixation and attachment, and the JuggerStitch knotless meniscal implant for meniscus repair.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Relign company profile →
FH Ortho
HQ: France
Website
- Description: Provider of orthopedic devices and instruments for surgeons worldwide, offering solutions for joint reconstruction and ligament repair. Products include hip, knee, and shoulder implants; forefoot and hindfoot implants and instruments; cruciate ligament repair products and techniques; and the TLS (Tape Locking Screw) system for anterior cruciate ligament reconstruction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FH Ortho company profile →
Tibion
HQ: United States
Website
- Description: Provider of non-invasive, actively assisted bionic mobility enhancement and rehabilitation devices for the mobility impaired, serving individuals recovering from surgery or affected by stroke, aging, or loss of muscle function; offerings include the PowerKnee.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tibion company profile →
Lanx
HQ: United States
Website
- Description: Provider of innovative spinal products for surgeons developed with proprietary technology. Founded in 2003 and led by experienced medical professionals and engineers, the company offers a robust, high-quality portfolio aimed at improving patient care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lanx company profile →
Renovis Surgical
HQ: United States
Website
- Description: Provider of orthopedic medical implants for surgeons and hospitals, offering spine fusion and stabilization solutions (Tesera SA Stand-Alone ALIF Cage, S100 Pedicle Screw System), trauma fixation screws (T700), hip and knee replacement systems (A400 Tapered Cementless Hip System, A200 Cruciate Retaining Knee System with E-MAX Highly Crosslinked Polyethylene), and the ReBOSSIS biosynthetic bone scaffold.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Renovis Surgical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CellRight Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CellRight Technologies
2.2 - Growth funds investing in similar companies to CellRight Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CellRight Technologies
4.2 - Public trading comparable groups for CellRight Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →